Skip to content

Clinical trials

Glomerulonephritis, IGA trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Country / region: Australia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20184
20191
20204
20215
20226
20234
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting8
Recruiting8
Terminated4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Alexion Pharmaceuticals, Inc.3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
The George Institute3
Calliditas Therapeutics AB2
ADARx Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Alpine Immune Sciences, Inc.1
Arrowhead Pharmaceuticals1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA34
Glomerulonephritis11
Kidney Diseases9
Renal Insufficiency, Chronic9
Proteinuria7
Urologic Diseases6
Autoimmune Diseases3
Diabetic Nephropathies3
Immune System Diseases3
Lupus Nephritis3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.